Successful Demonstration Of Dual Targeting With Duocalin Technology ...
Pieris AG's proprietary Duocalin technology has successfully demonstrated dual targeting potential. ... A Duocalin binds two separate therapeutic targets in ...General Health Articles | Emaxhealth | Page 324
... Of Dual Targeting With Duocalin Technology. Submitted by: hareyan ... Pieris AG's proprietary Duocalin technology has successfully demonstrated dual ...Pieris progresses development of its proprietary biotherapeutics platform.
Pieris AG, (Freising-Weihenstephan, Germany) a bio-pharmaceuticalcompany developing Anticalins, a novel class of ... proprietary Duocalin technology has ...Pieris progresses development of its proprietary biotherapeutics ...
... successful demonstration of dual targeting with Duocalin. technology ... Duocalin binds two separate therapeutic targets in one easily produced protein using ...Bioentrepreneur - Start-up Profiles - Pieris ProteoLab
Bioentrepreneur: Comprehensive information on biotechnology startups ... fusing two anticalins to form a "duocalin," agents can be created that bind to ...Presseportal: Pieris AG - Pieris progresses development of its ...
Pieris AG: Freising-Weihenstephan, Germany (ots) - Pieris AG, a bio-pharmaceutical company developing Anticalins® ... A Duocalin binds two separate ...